Colleen Flanigan
Biographic Data
| ID | 6072966 |
|---|---|
| NAME | Colleen Flanigan |
| GIVEN NAMES | Colleen |
| FAMILY NAME | Flanigan |
| SIGNATURE | FLANIGAN C |
| AFFILIATIONS | Jon E. Zibbell is with the Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA. Rachel Hart-Malloy and Colleen Flanigan are with the AIDS Institute, New York State Department of Health, Albany. Rachel Hart-Malloy is also with the Department of Epidemiology and Biostatistics, University at Albany, State University of New York. John Barry and Lillian Fan are with the Southern Tier AIDS Program, Broome County, NY. |
| ORCID | 0000-0001-6480-441X |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 5 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 1 |
Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006
Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics
Objectives. We investigated a cluster of new hepatitis C cases in rural New York among a cohort of young people who inject drugs (PWID) and misuse prescription opioid analgesics (POA). Methods. We recruited a purposive sample of PWID from Cortland County for an in-person survey and HCV rapid antibody test (March–July 2012). We examined sociodemographics, drugs currently injected, and lifetime and recent injection behaviors to ascertain associatio…
Estimating HCV Prevalence at the State Level
The degree to which case surveillance captures persons ever infected with HCV is unknown. We determined the discrepancy between HCV seroprevalence, estimated from national survey data, among adults in New York State in 2008 (n = 286 262, or 1.95%) and the number of infected persons reported to the state’s surveillance hepatitis registries (n = 144 015). Findings suggest the need to strengthen the existing surveillance system
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users
Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics
Objectives. We investigated a cluster of new hepatitis C cases in rural New York among a cohort of young people who inject drugs (PWID) and misuse prescription opioid analgesics (POA). Methods. We recruited a purposive sample of PWID from Cortland County for an in-person survey and HCV rapid antibody test (March–July 2012). We examined sociodemographics, drugs currently injected, and lifetime and recent injection behaviors to ascertain associatio…
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users
Estimating HCV Prevalence at the State Level
The degree to which case surveillance captures persons ever infected with HCV is unknown. We determined the discrepancy between HCV seroprevalence, estimated from national survey data, among adults in New York State in 2008 (n = 286 262, or 1.95%) and the number of infected persons reported to the state’s surveillance hepatitis registries (n = 144 015). Findings suggest the need to strengthen the existing surveillance system
Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics
Objectives. We investigated a cluster of new hepatitis C cases in rural New York among a cohort of young people who inject drugs (PWID) and misuse prescription opioid analgesics (POA). Methods. We recruited a purposive sample of PWID from Cortland County for an in-person survey and HCV rapid antibody test (March–July 2012). We examined sociodemographics, drugs currently injected, and lifetime and recent injection behaviors to ascertain associatio…
Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006
Hepatitis C virus research (4 works) · Medicine (4 works) · Environmental health (3 works) · Hepatitis C (3 works) · Virology (3 works) · Computer Science (2 works) · Demography (2 works) · Family medicine (2 works) · Hepatitis B Virus Studies (2 works) · HIV, Drug Use, Sexual Risk (2 works)